Connect Biopharma Holdings Limited
Connect Biopharma Holdings Limited (CNTB) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cntb · stock forecast · 5 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$6.00
Consensus
$5.00
+127.3% upside
Low
$4.00
Median: $5 · Last Close: $2.20
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$5.00
127.3% upside
High Target
$6
172.7%
Low Target
$4
81.8%
Current Price
$2.20
as of today
Based on analyst price targets, the CNTB stock price prediction for the next 12 months ranges from $4 to $6. The consensus CNTB price forecast of $5.00 implies 127.3% upside from the current price of $2.20.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.12 | ↓ 3.46% |
1-day model range: $2.08–$2.17. Peak: $2.17 (-3.46%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -27.6% |
| 2028 | — | -37.6% |
| 2029 | — | -41.9% |
| 2030 | — | -43.9% |
| 2031 | — | -44.9% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · CNTB · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-01 | BTIG | Maintains | Buy→Buy |
| 2026-03-31 | BTIG | Maintains | Buy→Buy |
| 2025-11-13 | BTIG | Maintains | Buy→Buy |
| 2025-08-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-09-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-06-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-04-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-09-13 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Connect Biopharma Holdings Limited (CNTB) stock. Of the recent 14 rating actions, 0 were upgrades and 1 were downgrades. 5 analysts currently cover CNTB.
Analyst Recommendation Trends
CNTB analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$5M
↓ 69.5% YoY
Revenue Next Year
$9M
↑ 77.0% YoY
EPS This Year
$-1.05
EPS Next Year
$-1.05
↓ 0.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast CNTB EPS of $-1.05 for the current fiscal year, based on estimates from 4 analysts. The CNTB revenue forecast is $5M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CNTB stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CNTB price target is $5.00 (+127.3% upside), with an analyst consensus of Buy.
The CNTB short-term stock prediction for tomorrow is $2.12 (-3.46%). The CNTB stock prediction for 2030 projects a range of $1–$1.
Connect Biopharma Holdings Limited trades on NASDAQ under the ticker CNTB. The CNTB stock outlook for 2027 is broadly positive, supported by a Buy consensus among 80% of covering analysts.
Frequently asked questions
CNTB forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month CNTB price target is $5.00, with a high forecast of $6.00 and a low of $4.00. The median price target is shown in the chart above when available. This implies +127.3% potential upside from the current price of $2.20.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.